Carbaglu (Orphan Europe, SARL)
Welcome to the PulseAid listing for the Carbaglu drug offered from Orphan Europe, SARL. This Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Orphan Europe, SARL |
NON-PROPRIETARY NAME: | Carglumic Acid |
SUBSTANCE NAME: | CARGLUMIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-03-18 |
END MARKETING DATE: | 0000-00-00 |
Carbaglu HUMAN PRESCRIPTION DRUG Details:
Item Description | Carbaglu from Orphan Europe, SARL |
LABELER NAME: | Orphan Europe, SARL |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2010-03-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52276-312_9e3720cb-15e2-ac00-e3de-3c4c82870d33 |
PRODUCT NDC: | 52276-312 |
APPLICATION NUMBER: | NDA022562 |
Other CARGLUMIC ACID Pharmaceutical Manufacturers / Labelers: